Medicine and Dentistry
Total Hip Arthroplasty
100%
Hip Arthroplasty
72%
Malignant Neoplasm
66%
Myocardial Infarction
62%
Apoplexy
51%
Antithrombotic
44%
Triage
39%
Vascular Surgery
33%
Nonsteroid Antiinflammatory Agent
33%
Cohort Analysis
33%
Atrial Fibrillation
33%
Anticoagulant Therapy
22%
Proportional Hazards Model
22%
Cardiovascular System
21%
Hazard Ratio
21%
Resuscitation
20%
Case-Control Study
19%
Heart Surgery
19%
Cerebral Hemorrhage
18%
Odds Ratio
18%
Inflammatory Arthritis
18%
Rheumatoid Arthritis
18%
Shoulder Pain
17%
Artificial Respiration
17%
Chronic Obstructive Pulmonary Disease
17%
Emergency Care
16%
Analgesia
16%
Substance Abuse
16%
Primary Health Care
16%
Dual Diagnosis
16%
Low Back Pain
16%
Musculoskeletal Pain
16%
Patient Population
16%
Shared Decision Making
16%
Chronic Disease
16%
Beta Adrenergic Receptor Blocking Agent
16%
Out of Hospital Cardiac Arrest
16%
Abdominal Aortic Aneurysm
16%
Acute Kidney Injury
16%
Reperfusion Injury
16%
ST Elevation
16%
Non Invasive Procedure
16%
Hydroxylapatite
16%
Hemoglobin A1c
16%
Fetus Growth
16%
Urinary System
16%
Patient with Diabetes
16%
Congenital Heart Defect
16%
Disseminated Herpes Zoster
16%
Infection
16%
Glycon
16%
Femur Fracture
16%
Cyclooxygenase 2
16%
Magnesium
16%
middle age
16%
Acute Coronary Syndrome
16%
Fever of Unknown Origin
16%
Venous Thromboembolism
16%
Dying
16%
Bariatric Surgery
16%
Cost Benefit Analysis
16%
Infarction
16%
Sulfonylurea
16%
Arthroplasty
16%
Self-Administration
16%
Statin
16%
Hip Disease
16%
Intensive Care
16%
Vitamin K Antagonist
16%
Albumin
16%
Anemia
16%
Glycemic Control
16%
Acute Pancreatitis
16%
Lifespan
16%
Implant
15%
Osteoarthritis
15%
Hypolipidemic Agent
14%
Health Care Cost
14%
Logistic Regression Analysis
13%
Invasive Procedure
13%
Healthcare Practitioner
12%
Creatinine
12%
Mortality Rate
10%
Gene Linkage
10%
Intensive Care Unit
10%
Androgen
10%
Prevalence
9%
Quality Adjusted Life Year
9%
Medicine
8%
Health System
8%
Lung Tuberculosis
8%
Overall Survival
8%
Internal Fixation
8%
Amputation
8%
Short Course Therapy
8%
Diabetes Mellitus
7%
Cancer Diagnosis
6%
Disease Free Survival
6%
Ischemic Heart Disease
6%
Platelet
6%
Keyphrases
Hospitalization
55%
Confidence Interval
44%
Denmark
39%
Population-based Case-control Study
36%
Myocardial Infarction
33%
Primary Total Hip Arthroplasty
33%
Population-based
30%
Living with
28%
Total Hip Arthroplasty
25%
Patient Needs
20%
Healthcare Professionals
19%
Clinical Outcomes
19%
Hip Arthroplasty
19%
Clinical Database
19%
Arthroplasty Register
19%
Pre-admission
17%
National Cohort Study
17%
Health Practitioners
17%
Qualitative Needs Assessment
16%
Decisional Needs
16%
Assessment Study
16%
Subacromial Pain Syndrome
16%
Primary Care Management
16%
Artificial Intelligence
16%
Vignettes
16%
General Practitioners
16%
General Practice
16%
Interview Study
16%
Theoretical Domains Framework
16%
Musculoskeletal Pain
16%
Scoping Review
16%
Healthcare Settings
16%
Chronic musculoskeletal Pain
16%
Polypharmacy Review
16%
Multi-method Research
16%
Atraumatic
16%
Choosing Wisely
16%
Low Back Pain
16%
Shoulder Pain
16%
Low Back Pain Management
16%
Patients with Substance Use Disorders
16%
Rheumatoid Arthritis Patients
16%
Fever of Unknown Origin
16%
Platelets
16%
Severe Traumatic Brain Injury (sTBI)
16%
Ischemia-reperfusion Injury
16%
Congenital Heart Defects
16%
Length of Stay
16%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
16%
Antidepressants
16%
Oral Anticoagulant Therapy
16%
Invasive Mechanical Ventilation
16%
Readmission
16%
Health Registries
16%
Danes
16%
Herpes Zoster
16%
Trial Population
16%
Disease Course
16%
Acute Stroke
16%
Antipsychotics
16%
Cyclooxygenase-2 Inhibitors
16%
Audit Study
16%
Preventable Death
16%
Atrial Fibrillation
16%
Chronic Obstructive Pulmonary Disease Patient
16%
Directly Observed Treatment
16%
Secondary Medical Prevention
16%
Cardiac Surgical Patients
16%
Genetic Susceptibility
16%
Non-aspirin Non-steroidal Anti-inflammatory Drugs
16%
Venous Thromboembolism
16%
Anemia
16%
Middle-aged
16%
Urinary Albumin Excretion
16%
Fetal Growth
16%
Therapy Outcome
16%
Statin Use
16%
Arthroplasty
16%
Area at Risk
16%
Extracranial Stenosis
16%
Glargine
16%
Total Hip Arthroplasty Outcomes
16%
Hip Disorders
16%
Infarct Size
16%
Population-based Study
16%
Future Demand
16%
90-day Mortality
16%
Hospital Accreditation
16%
Acute Pancreatitis
16%
Long-acting Insulin Analog
16%
Ruptured Abdominal Aortic Aneurysm (rAAA)
16%
Thrombosis
16%
Relative Risk
14%
Albumin-to-creatinine Ratio
13%
Patients with Cancer
12%
Intracranial Stenosis
12%
Primary THA
11%
Emergency Medical Communication Centre
11%
Troponin
11%
Creatine Kinase
11%
Nursing and Health Professions
Health Care Personnel
57%
Confidence Interval
41%
Anticoagulant Agent
35%
Clinical Outcome
35%
Total Hip Prosthesis
33%
Atrial Fibrillation
33%
Obstructive Lung Disease
33%
Cerebrovascular Accident
31%
Hip Arthroplasty
20%
Health Care Cost
19%
Brain Hemorrhage
18%
Shoulder Pain
17%
Low Back Pain
16%
Imaging
16%
Analgesia
16%
Musculoskeletal Pain
16%
Shared Decision-Making
16%
Primary Medical Care
16%
General Practice
16%
Polypharmacy
16%
Pill
16%
Beta Adrenergic Receptor Blocking Agent
16%
Albumin
16%
Hospital Accreditation
16%
Anticoagulant Therapy
16%
Warfarin
16%
Case-Control Study
16%
Postoperative Complication
16%
Treatment Outcome
16%
Artificial Respiration
16%
Length of Stay
16%
Predictive Value
16%
Hospital Readmission
16%
Statin (Protein)
16%
Hormone Substitution
16%
Propensity Score
16%
Nonsteroid Antiinflammatory Agent
16%
Outpatient
16%
Disease Course
16%
Traumatic Brain Injury
16%
Compliance
16%
Anemia
16%
Vascular Surgery
16%
Abdominal Aortic Aneurysm
16%
Total Quality Management
14%
Confounding Factor
12%
Rate Ratio
11%
Odds Ratio
11%
Proportional Hazards Model
10%
Hazard Ratio
10%
Health Care
10%
Creatinine
9%
Logistic Regression Analysis
8%
Mortality Rate
8%
Amputation
8%
Heart Infarction
8%
Drug Self Administration
8%
Clinical Practice
8%
Reimbursement
7%
Diabetes Mellitus
7%
Self Care
6%
International Normalized Ratio
6%
Rivaroxaban
6%
University Hospital
5%
Effect Size
5%